Appropriations for sundry civil expenses of the government. Message from the President of the United States, to the House of Representatives, concerning the act making appropriations for sundry civil expenses of the government. July 31, 1876. -- Referred to the Committee on Appropriations and ordered to be printed

• Record Nr.: UNINA9911077082203321
• Pubbl/distr/stampa: [Washington, D.C.] : , : [U.S. Government Printing Office], , 1876
• Descrizione fisica: 1 online resource (2 pages)
• Collana: Ex. doc. / 44th Congress, 1st session. House ; ; no. 187; [United States congressional serial set] ; ; [serial no. 1691]
• Altri autori (Persone): GrantUlysses S <1822-1885.> (Ulysses Simpson)
• Soggetti: Budget process; Executive-legislative relations; Legislative materials.
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Batch processed record: Metadata reviewed, not verified. Some fields updated by batch processes.; FDLP item number not assigned.

Lyric texts and lyric consciousness : the birth of a genre from archaic Greece to Augustan Rome / / Paul Allen Miller

• Record Nr.: UNINA9911136959603321
• Autore: Miller Paul Allen <1959->
• Pubbl/distr/stampa: London ; ; New York, : Routledge, 1994
• ISBN: 1-134-84662-2; 1-282-76851-4; 9786612768514; 0-203-97461-1; 9780203974612
• Edizione: [1st ed.]
• Descrizione fisica: 1 online resource (viii, 240 pages)
• Disciplina: 884.0109; 884/.0109
• Soggetti: Classical poetry - History and criticism; Lyric poetry - History and criticism
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: LYRIC TEXTS AND LYRIC CONSCIOUSNESS The Birth of a Genre from Archaic Greece to Augustan Rome; Copyright; CONTENTS; Acknowledgements; 1 The Subject Of The Text; 2 Epos And Iambos Or Archilochus Meets The Wolfman; 3 De Generibus Disputandum Est; 4 The Garden Of Forking Paths: Catullus And The Birth Of The Collection; 5 A Poet'S Place: Sappho And The Melic Discourse Of Archaic Greece; 6 Sapphica Puella: The Triple-Faceted Object Of Catullan Desire; 7 Rome, Alexandria, And The Politics Of Lyric; 8 Horace, Mercury, And Augustus; 9 Conclusion: Of Writings And Subjects; Appendix I; Appendix II; Notes; References; Index
• Sommario/riassunto: Lyric Texts and Lyric Consciousness presents a model for studying the history of lyric as a genre. Prof Miller draws a distinction between the work of the Greek lyrists and the more condensed, personal poetry that we associate with lyric. He then confronts the theoretical issues and presents a sophisticated, Bakhtinian reading of the development of the lyric form from its origins in archaic Greece to the more individualist style of Augustan Rome. This book will appeal to classicists and, since ; English translations of passages from the ancient authors are provided, to those who special

Understanding the benefits and risks of pharmaceuticals : workshop summary, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy / / Leslie Pray, rapporteur ; Institute of Medicine of the National Academies

• Record Nr.: UNINA9911143028903321
• Pubbl/distr/stampa: Washington, D.C., : National Academies Press, c2007
• ISBN: 0-309-17976-9; 1-280-94146-4; 9786610941469; 0-309-10739-3
• Edizione: [1st ed.]
• Descrizione fisica: 1 online resource (97 p.)
• Altri autori (Persone): PrayLeslie A
• Disciplina: 615
• Soggetti: Drugs; Drugs - Side effects; Chemotherapy; Chemotherapy - Side effects
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references.
• Nota di contenuto: ""Front Matter""; ""Reviewers""; ""Contents""; ""Summary""; ""1 Introduction""; ""2 Regulatory Assessment""; ""3 The Challenge of Communication""; ""4 The Importance of Context in Healthcare Decision Making""; ""5 Patient Experience with Drugs over Time""; ""6 Next Steps""; ""References""; ""Appendixes""; ""A Workshop Agenda""; ""B Discussion Leader and Speaker Biographies""
• Sommario/riassunto: All pharmaceutical products have inherent risks, and their use involves trade-offs between their therapeutic benefits and their risks. However, the public has a limited understanding of the benefits and risks of drugs, and many individuals believe that drugs approved by the U.S. Food and Drug Administration (FDA) carry no risks. The FDA is ; responsible for evaluating and balancing the potential risks of drugs with their potential benefits. Assessing, managing, and communicating the benefit-risk profile of a pharmaceutical product is a complex and nuanced scientific, political, and sociological challenge. Once the assessment is made, the FDA is then responsible for managing how to communicate these risks and make healthcare decisions based on them. To explore these issues, the Forum on Drug Discovery, Development, and Translation conducted a public workshop entitled Understanding the Benefits and Risks of Pharmaceuticals, with the broad goals of gaining a better understanding of the current system used to evaluate benefit and risk, and to identify opportunities for improvement. This workshop was held in Washington, D.C., on May 30-31, 2006. The benefit-risk profiles of pharmaceuticals are constantly evolving as new data are collected throughout the life cycle of a drug. Discussions during the workshop focused on the following: (1) premarket assessment, during which clinical trial data are used to assess benefit and risk; (2) communication of that information to prescribing physicians and their patients; (3) healthcare decisions made by prescribing physicians and their patients; and (4) the accumulation of benefit-risk information from postmarketing experience, which feeds back into the other phases. Understanding the Benefits and Risks of Pharmaceuticals: Workshop Summary explains in detail the discussions during this workshop.